Cardiovascular Drugs Market 2020: Technological Advancements, Research Report, Industry Analysis, Share and Size Forecas

1. Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication, By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026 Buy Now Sample PDF Get Discount Published Date: April 2019 Region: Global Report Format: PDF Base Year: 2018 Fortune Business Insights Pvt Ltd.

2. Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication, By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026 Report Highlights: The global cardiovascular drugs market size is set to touch USD 63.96 billion by 2026, exhibiting a CAGR of 3.8% during the forecast period. Increasing incidence of cardiovascular disorders will be one of the central driving forces of growth for this market in the next decade. According to the Global Burden of Disease Study 2017, cardiovascular disorder (CVD) is the most common chronic disease, killing around 17.8 million people annually. Of these, close to 82% of the deaths occur in low and middle-income countries. The World Health Organization (WHO) estimates that 80% of CVD deaths are caused by heart attack and strokes. Fortune Business Insights, through its report, titled “Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026”, brings out a comprehensive analysis of the factors and dynamics that are likely to influence the share, size, and overall growth of the market during the forecast period. Fortune Business Insights Pvt Ltd.

3. Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication, By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026 Rising Demand for Effective Treatment Drugs to Stir Innovation One of the leading cardiovascular drugs market trends is the steady spread of awareness about the effects of CVDs. This is causing an upsurge in the demand for CVD drugs, a need that is being bolstered by rising pollution levels and an increasingly sedentary lifestyle. The response from the industry has been positive as many companies are coming out novel drugs to cure such conditions as effectively as possible. For instance, Bristol-Myers Squibb and Pfizer jointly developed Eliquis, a low-risk cardiovascular drug that was rapidly adopted by patients and doctors alike. These developments are expected to vastly enhance the potential of this market in the near future. High Incidence Rate of Risk Factors to Fuel the Market in North America North America generated a revenue of USD 21.89 billion in 2018 and is anticipated to continue its dominance of the cardiovascular drugs market share in the forecast period. The main factors driving the market include increasing prevalence of risk factors such as obesity and diabetes that are associated with cardiovascular conditions, presence of large companies, and growing incidence of CVDs in the region. Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/cardiovascular-therapeutics-market- 100379 Fortune Business Insights Pvt Ltd.

4. Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication, By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026 List of the companies functioning in the global market are: • Merck & Co., Inc. • Pfizer Inc. • F. Hoffmann-La Roche Ltd. • Janssen Pharmaceuticals, Inc. • Bristol-Myers Squibb Company • Bayer AG • Novartis AG • Gilead Sciences, Inc. • AstraZeneca Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiovascular- therapeutics-market-100379 Fortune Business Insights Pvt Ltd.

5. Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication, By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026 About Us: Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. Phone: US: +1 424 253 0390 UK: +44 2071 939123 APAC: +91 744 740 1245 Email: sales@fortunebusinessinsights.com Fortune Business Insights Pvt Ltd.